Publication
2015
Universal Public Finance of Tuberculosis Treatment in India: An Extended CEA
This paper evaluates the consequences of universal public finance (UPF) for tuberculosis treatment in India …
This paper evaluates the consequences of universal public finance (UPF) for tuberculosis treatment in India using extended cost-effectiveness analysis (ECEA). The authors evaluated the impact of UPF on health gains, financial consequences, and catastrophic health expenditures, and concluded that the health gains and insurance value of UPF would accrue mostly to the poor. However, reductions in out-of-pocket expenditures were found to be more uniformly distributed across income quintiles. A variant on the base case suggests…
Health Outcomes
|
Health/Medicine
|
Asia & Pacific
|
Clinical Care
|
Priority Setting/Ethics
|
Costing Methods
|
Cost-Effectiveness Analysis
|
Infectious Diseases
|
Social Determinants
|
Health Systems
|
Policy/Regulation
|
Economics/Finance